comparemela.com
Home
Live Updates
Indias 1st homegrown mRNA Covid vax may have low market penetration: Report : comparemela.com
India's 1st homegrown mRNA Covid vax may have low market penetration: Report
The recently approved Pune-based Gennova Biopharmaceuticals' two-dose mRNA Covid-19 vaccine, expected to be soon available in the country, is likely to see low penetration in the Indian market, according to a report on Monday.The jab ...
Related Keywords
India
,
New Delhi
,
Delhi
,
Neha Myneni
,
Moderna Spikevax
,
National Technical Advisory Group On Immunisation
,
Pune Based Gennova Biopharmaceutical
,
Drugs Controller General
,
Pharma Analyst
,
While Moderna
,
National Technical Advisory Group
,
comparemela.com © 2020. All Rights Reserved.